Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Schedule an appointment today
Call to Schedule: 1-866-UH4-CARE
Find Clinical Trials & Studies
Visit the Research & Education Institute

STICH3C Study

Back to Search Results
Share
Facebook
X
Pinterest
LinkedIn
Email
Print
I'm Interested!
Fill out our online form

The Canadian CABG or PCI in Patients with Ischemic Cardiomyopathy Trial

  • Sex: Any
  • Age: Adult (18 - 64), Older Adult (65+)
  • Accepting Healthy People: No
  • Type: Observational
  • Trial Phase: NA
  • Conditions Being Studied: Coronary Artery Disease (CAD)

Study Purpose

The purpose of this study is to evaluate and compare the effectiveness of percutaneous coronary intervention (PCI – a minimally invasive procedure that goes through the skin into the blood system and up to the heart) against coronary artery bypass grafting (CABG – a surgery on the tubes that carry blood to the heart) in patients with multivessel coronary artery disease and ischemic left ventricular dysfunction (weak heart from reduced circulation secondary to the blockages).

Who Can Participate

Participants 18 years of age or older diagnosed with multivessel coronary artery disease with ejection fraction 40% or lower may be eligible for this study.

Principal Investigator
Rakesh Arora MD
Department/Division
Heart and Vascular (Cardiac Surgery)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

Get Directions
  • UH IRB: STUDY20230162
  • StudyID: 2023-01138
  • ClinicalTrials.gov: NCT05427370
I'm Interested!
Fill out our online form

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422